|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 44, 1413-1419, July 2003
Copyright © 2003 by American Society for Biochemistry and Molecular Biology
Methods |
Department of Biological Chemistry, Weizmann Institute of Science, 76100, Rehovot, Israel
1 To whom correspondence should be addressed. e-mail: tony.futerman{at}weizmann.ac.il
We describe a new method that permits quantification in the pmol to nmol range of three lyso-neutral glycosphingolipids (lyso-n-GSLs), glucosylsphingosine (GlcSph), galactosylsphingosine (GalSph), and lactosylsphingosine, in the same sample as neutral glycosphingolipids (n-GSLs). Lyso-n-GSLs and n-GSLs are initially obtained from a crude lipid extract using Sephadex G25 chromatography, followed by their isolation in one fraction, which is devoid of other contaminating lipids, by aminopropyl solid-phase chromatography. Lyso-n-GSLs and n-GSLs are subsequently separated from one another by weak cation exchange chromatography. N-GSLs are then deacylated by strong alkaline hydrolysis, and the N-deacylated-GSLs and lyso-n-GSLs are subsequently N-acetylated using [3H]acetic anhydride. An optimal concentration of 5 mM acetic anhydride was established, which gave >95% N-acetylation. We demonstrate the usefulness of this technique by showing an
40-fold increase of both GlcSph and glucosylceramide in brain tissue from a glucocerebrosidase-deficient mouse, as well as significant lactosylceramide accumulation.
The application and optimization of this technique for lyso-n-GSLs and lyso-GSLs will permit their quantification in small amounts of biological tissues, particularly in the GSL storage diseases, such as Gaucher and Krabbe's disease, in which GlcSph and GalSph, respectively, accumulate.
Abbreviations: C2-N-GSL, N-acetyl-GSL; GalSph, galactosylsphingosine; GlcSph, glucosylsphingosine; GSL, glycosphingolipid; LacCer, lactosylceramide; LacSph, lactosylsphingosine; lyso-n-GSL, lyso-neutral glycosphingolipid; n-GSL, neutral glycosphingolipid
Supplementary key words glucosylceramide galactosylceramide lactosylceramide Gaucher disease Krabbe's disease
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
T. Cohen, W. Auerbach, L. Ravid, J. Bodennec, A. Fein, A. H. Futerman, A. L. Joyner, and M. Horowitz The Exon 8-Containing Prosaposin Gene Splice Variant Is Dispensable for Mouse Development, Lysosomal Function, and Secretion Mol. Cell. Biol., March 15, 2005; 25(6): 2431 - 2440. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |